Effects of Backward Gait Training in Chronic Stroke Patients

Not Applicable

• Conditions: Chronic Stroke Patients
• Interventions: Other: Forward Walking Training; Other: Backward Walking Training

• Registration Number: NCT04903392
• Lead Sponsor: Bandırma Onyedi Eylül University

Brief Summary

Loss of motor control after stroke, muscle weakness, abnormal movement patterns, spasticity, range of motion limitations and sensory dysfunction, resulting in a decrease in the load transferred to the affected limb, changes in gait pattern and balance skills. Post-stroke muscle weakness has been shown to occur not only in the lower and upper extremity muscles but also in the respiratory muscles. It was found that the plantar pressure distribution in the affected side feet was decreased in individuals with stroke and this situation negatively affected the walking function. A systematic review of treadmill training revealed that treadmill training significantly increased walking speed and walking distance. Learning to walk backwards is also recommended to improve the movement components required for walking forward. As a result of the investigations, although there are studies about the effects of back-walking training on walking and balance function in chronic stroke patients, there is no study investigating the effects on plantar pressure distribution and respiratory parameters. Therefore, this study, which planned to investigate the effects of treadmill retching training on balance, plantar pressure distribution and respiratory parameters in chronic stroke patients, will contribute to the literature.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-05-18
• Study First Submitted QC: 2021-05-21
• Study First Posted: 2021-05-26
• Study Start: 2021-12-01
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-13
• Last Update Posted: 2022-03-15
• Primary Completion: 2022-12-01
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

• Volunteering to participate in the study
• More than 6 months have passed since the onset of stroke
• First time stroke diagnosis
• Being between the ages of 40-65
• Spasticity severity in lower extremity less than 3 according to Modified Ashworth Scale,
• Being medically stable
• Ability to walk 10 meters and above without assistance

Exclusion Criteria

• Presence of other neurological or orthopedic diseases that affect standing and walking involving the lower limbs
• Uncontrollable Hypertension
• Having been diagnosed with any pulmonary disease
• Severe cardiac conditions
• Uncontrollable DM
• Lack of cooperation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Forward Walking Group	Forward Walking Training	Conventional therapy + Forward Walking Training
Backward Walking Group	Backward Walking Training	Conventional therapy + Backward Walking Training

Primary Outcome Measures

Name	Time	Method
Pulmonary function (Forced expiratory volume in the first second (FEV1))	6 weeks	Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, forced expiratory volume in the first second (FEV1) will be evaluated.
Plantar pressure assessment	6 weeks	Plantar pressure distribution will be evaluated.
Pulmonary function (Forced vital capacity (FVC))	6 weeks	Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, forced vital capacity (FVC) will be evaluated.
Pulmonary function (FEV1 / FVC)	6 weeks	Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, FEV1 / FVC will be evaluated.
Pulmonary function (Peak flow rate (PEF))	6 weeks	Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, peak flow rate (PEF) will be evaluated.
Respiratory Muscle Strength	6 weeks	Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) will be measured using portable, electronic, oral pressure measuring device
Balance assessment	6 weeks	Static and dynamic balance will be evaluated with The Korebalance Premiere device.
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))	6 weeks	Pulmonary function will be evaluated with the spirometry. Dynamic lung volume measurements will be made according to American Thoracic Society and European Respiratory Society criteria. With the device, flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be evaluated.

Trial Locations

Locations (1)

Burçin Akçay; 🇹🇷 Balıkesir, Turkey